Accelus

Kevin Mcgann is the CEO of Accelus.

The decision makers in Accelus are Alex Lukianov, Brian Ranft, Chris Walsh, etc. Click to Find Accelus decision makers emails.

Accelus specializes in procedure-enabling technologies that enhance minimally invasive spine surgery (MIS). Their services include advanced robotics, navigation systems, and adaptive geometry solutions designed to improve surgical precision and patient outcomes. By focusing on these innovative technologies, Accelus aims to make spine surgery more accessible to underserved markets.

Accelus's technology improves minimally invasive spine surgery by integrating robotics and advanced navigation systems that allow surgeons to perform procedures with greater accuracy and less trauma to surrounding tissues. This results in reduced recovery times, less postoperative pain, and overall better outcomes for patients. The company's commitment to adaptive geometry further enhances the effectiveness of their implants and surgical tools.

Accelus primarily serves the healthcare industry, specifically focusing on the field of spine surgery. Their innovative technologies are designed to assist hospitals, surgical centers, and healthcare providers in delivering high-quality care to patients requiring spinal interventions. By targeting underserved markets, Accelus aims to expand access to advanced surgical solutions.

The phrase 'Access Without Compromise' reflects Accelus's commitment to providing high-quality, innovative surgical solutions to all patients, regardless of their geographical or economic circumstances. This mission underscores the company's goal to eliminate barriers to advanced spine surgery technologies, ensuring that even those in underserved markets can benefit from minimally invasive procedures.

Robotics play a crucial role in Accelus's surgical solutions by enhancing the precision and control of spine surgery procedures. The robotic systems developed by Accelus allow surgeons to perform complex maneuvers with greater accuracy, reducing the risk of complications and improving overall surgical outcomes. This technology also facilitates minimally invasive techniques, which can lead to quicker recovery times for patients.

Accelus ensures the safety and efficacy of its surgical technologies through rigorous testing and validation processes. The company adheres to strict regulatory standards and collaborates with leading healthcare professionals to conduct clinical studies that assess the performance of their products. Continuous feedback from surgeons and patients also informs ongoing improvements and innovations in their technology.